revenue deals the cherry on top to come ... i ssuspect once the market sees the business plan workig they will pile back in and the old highs of .26 are possible ....
this stock should reflect future earnings well before they hit the bottom line. a resmed clone as far as creating and meeting its market is concerned. it will happen imo.
cheap as cheaps right now. should be .07+ right now.